Jing Jia Selected Research

H-Tyr-Ser-Leu-OH

1/2018	Therapeutic effects of tyroserleutide on lung metastasis of human hepatocellular carcinoma SK-HEP-1 and its mechanism affecting ICAM-1 and MMP-2 and -9.
2/2014	Effects of Tyroserleutide on phosphatidylinositol 3'-kinase/AKT pathway in human hepatocellular carcinoma cell.
11/2008	Tripeptide tyroserleutide plus doxorubicin: therapeutic synergy and side effect attenuation.
2/2008	Effects of tyroserleutide on gene expression of calmodulin and PI3K in hepatocellular carcinoma.
6/2006	The effect of tripeptide tyroserleutide (YSL) on animal models of hepatocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jing Jia Research Topics

Disease

59	Neoplasms (Cancer) 01/2022 - 09/2005
12	Neoplasm Metastasis (Metastasis) 11/2021 - 01/2013
10	Stomach Neoplasms (Stomach Cancer) 11/2021 - 04/2007
9	Prostatic Neoplasms (Prostate Cancer) 11/2020 - 02/2016
8	Inflammation (Inflammations) 01/2022 - 02/2017
6	Melanoma (Melanoma, Malignant) 01/2022 - 04/2007
5	Atherosclerosis 01/2022 - 01/2019
5	Infections 09/2020 - 05/2015
5	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 02/2008
5	Lung Neoplasms (Lung Cancer) 09/2017 - 04/2007
5	Hypoxia (Hypoxemia) 01/2017 - 03/2015
5	Pulmonary Hypertension 07/2015 - 07/2011
4	Neuroinflammatory Diseases 01/2022 - 11/2017
4	Carcinogenesis 01/2022 - 01/2011
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2014
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 06/2013
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 10/2015 - 03/2012
3	Cognitive Dysfunction 01/2022 - 01/2018
3	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2007
3	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021 - 12/2016
3	COVID-19 10/2021 - 08/2020
3	Liver Neoplasms (Liver Cancer) 07/2021 - 11/2008
3	Heart Failure 09/2020 - 01/2017
3	Disease Progression 06/2019 - 01/2013
2	Brain Ischemia (Cerebral Ischemia) 08/2022 - 04/2021
2	Brain Injuries (Brain Injury) 08/2022 - 01/2022
2	Ischemic Stroke 05/2022 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2021 - 01/2015
2	Glioma (Gliomas) 07/2021 - 01/2020
2	Nasopharyngeal Carcinoma 07/2021 - 02/2008
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2020
2	Hypertension (High Blood Pressure) 01/2021 - 01/2019
2	Insulin Resistance 12/2020 - 06/2017
2	Hot Flashes 11/2020 - 01/2018
2	Ischemia 08/2020 - 12/2011
2	Type 2 Diabetes Mellitus (MODY) 07/2020 - 01/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 12/2016
2	Fibrosis (Cirrhosis) 06/2019 - 05/2016
2	Body Weight (Weight, Body) 03/2018 - 01/2018
2	Non-alcoholic Fatty Liver Disease 01/2018 - 06/2017
2	Pre-Eclampsia (Preeclampsia) 10/2017 - 10/2016
2	Choledocholithiasis 09/2017 - 08/2017
2	Cholecystitis 09/2017 - 08/2017

Drug/Important Bio-Agent (IBA)

18	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2006
7	Messenger RNA (mRNA)IBA 10/2021 - 03/2006
7	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2011
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2008
5	Small Interfering RNA (siRNA)IBA 08/2022 - 07/2015
5	CytokinesIBA 01/2022 - 07/2011
5	Biological ProductsIBA 01/2021 - 01/2017
5	H-Tyr-Ser-Leu-OHIBA 01/2018 - 06/2006
5	tripeptide tyroservatideIBA 01/2016 - 03/2006
4	Glucose (Dextrose)FDA LinkGeneric 12/2022 - 06/2017
4	Long Noncoding RNAIBA 01/2020 - 06/2016
4	Peptides (Polypeptides)IBA 03/2018 - 06/2008
4	Imatinib Mesylate (Gleevec)FDA Link 10/2015 - 03/2012
3	Interleukin-6 (Interleukin 6)IBA 12/2022 - 08/2020
3	InterleukinsIBA 12/2022 - 02/2017
3	RNA (Ribonucleic Acid)IBA 10/2021 - 10/2016
3	Polysaccharides (Glycans)IBA 07/2021 - 05/2011
3	Pharmaceutical PreparationsIBA 01/2020 - 04/2007
3	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2018 - 05/2016
3	Caspase 3 (Caspase-3)IBA 10/2017 - 10/2016
3	Factor V (Coagulation Factor V)IBA 08/2017 - 02/2016
3	cholesteryl-6-pyrenylhexanoate (ChPH)IBA 07/2015 - 03/2015
3	TRPC6 Cation ChannelIBA 07/2015 - 02/2014
2	Dexmedetomidine FDA Link 12/2022 - 07/2021
2	CholesterolIBA 05/2022 - 10/2020
2	Superoxide DismutaseIBA 01/2022 - 08/2020
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2018
2	Malondialdehyde (Propanedial)IBA 01/2022 - 08/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 08/2020
2	EnzymesIBA 11/2021 - 01/2019
2	VaccinesIBA 09/2021 - 01/2019
2	AntioxidantsIBA 07/2021 - 04/2021
2	CateninsIBA 07/2021 - 03/2017
2	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 03/2021 - 11/2018
2	ProteomeIBA 01/2021 - 01/2021
2	Sincalide FDA Link 01/2021 - 01/2020
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2020 - 03/2015
2	Estrogens (Estrogen)FDA Link 11/2020 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2020 - 02/2016
2	Glutathione (Reduced Glutathione)IBA 04/2020 - 08/2010
2	Silybin (Lagosa)IBA 01/2020 - 12/2018
2	Docetaxel (Taxotere)FDA Link 01/2019 - 10/2017
2	Therapeutic UsesIBA 01/2018 - 01/2016
2	RemifeminIBA 01/2018 - 01/2013
2	Amino Acids FDA Link 11/2017 - 01/2006
2	CalciumIBA 06/2015 - 03/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015 - 11/2008
2	Antineoplastic Agents (Antineoplastics)IBA 01/2015 - 03/2006
2	3' Untranslated Regions (3' UTR)IBA 03/2014 - 10/2013

Therapy/Procedure

12	Therapeutics 07/2021 - 06/2008
4	Drug Therapy (Chemotherapy) 01/2019 - 11/2008
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2020 - 01/2017
2	Length of Stay 12/2022 - 01/2018
2	Radiotherapy 10/2021 - 01/2015
2	Castration 01/2020 - 01/2019
2	Activities of Daily Living (ADL) 01/2019 - 01/2019
2	Operative Time 01/2018 - 09/2017